Separation of xylenes on Y zeolites in the vapor phase. 1. Determination of the adsorption equilibrium parameters and of the kinetic regime

1985 ◽  
Vol 24 (1) ◽  
pp. 78-83 ◽  
Author(s):  
Elio Santacesaria ◽  
Davino Gelosa ◽  
Pietro Danise ◽  
Sergio Carra
Keyword(s):  
Vapor Phase ◽  
Adsorption Equilibrium ◽  
Phase 1 ◽  
Kinetic Regime ◽  
Y Zeolites

scholarly journals Gas Chromatographic Determination of Traces of Accelerants in Physical Evidence

1972 ◽  
Vol 55 (4) ◽  
pp. 840-845 ◽  
Author(s):  
Charles R Midkiff ◽  
Willard D Washington
Keyword(s):  
Liquid Chromatography ◽  
Solvent Extraction ◽  
Vapor Phase ◽  
Selection Criteria ◽  
Chromatographic Determination ◽  
Operating Parameters ◽  
Gas Liquid Chromatography ◽  
Internal Standards ◽  
Physical Evidence

Techniques developed for use with gas-liquid chromatography for the examination of evidence collected at the scene of suspected arson fires and firebombings are discussed. Both solvent extraction and vapor phase examinations are employed. Internal standards are used for the identification of specific components in actual samples to allow confirmation of hydrocarbon type, e.g., gasoline and kerosene. Operating parameters and solvent selection criteria are included. Results obtained from known materials and residual hydrocarbons in actual samples are compared.

scholarly journals APPLICATION OF MATHEMATICAL PLANNING OF THE EXPERIMENT IN THE CHOOSING THE OPTIMUM CONDITIONS OF THE VAPOR-PHASE GAS-CHROMATOGRAPHIC DETERMINATION OF FORMALDEHYDE IN THE URINE

2018 ◽  
Vol 97 (10) ◽  
pp. 985-989 ◽  
Author(s):  
Аnton N. Alekseenko ◽  
O. M. Zhurba
Keyword(s):  
Mathematical Model ◽  
Vapor Phase ◽  
Statistical Processing ◽  
Analytical Signal ◽  
Heating Time ◽  
Gas Extraction ◽  
Optimal Conditions ◽  
Steep Ascent ◽  
The Mathematical Model

Introduction. There was substantiated a method for the determination of formaldehyde by vapor-phase gas chromatography by the use of derivatizing reagent o-(2,3,4,5,6-pentafluorbenzyl)hydroxylamine. Material and methods. Formaldehyde in urine was derivatized to o-pentafluorobenzyloxime and recovered to the vapor phase by heating the urine sample with o-(2,3,4,5,6-pentafluorbenzyl)hydroxylamine in a sealed vial. Gas-chromatographic analysis of the vapor-air phase was performed in a mode of the temperature gradient on a capillary column HP-5 with a flame ionization detector. Identification of the analyte in the form of the derivative-o- pentafluorobenzyloxime of formaldehyde was carried out according to the absolute retention time, which was established by comparing the chromatograms of model formaldehyde mixtures in the urine of different concentrations. Results. The optimal conditions for gas extraction are selected using mathematical experimental planning. The most important factors of gas extraction in the vapor-phase analysis are the temperature and time of the establishment of the interphase equilibrium with heating. From the experimentally obtained curves of the analytical signal on the temperature and the heating time, the zero level and the interval of variation of these factors are chosen. A matrix for planning a 2-factor experiment was constructed. The coefficients of the mathematical model are determined. There was carried out statistical processing of the experimental data, which was reduced to the estimation of the reproducibility of the optimization parameter and to the evaluation of the significance of the coefficient of the mathematical model. The adequacy of the mathematical model was evaluated, its interpretation was carried out. Discussion. The peak area of the analyte increases with the elevating the temperature and heating time, due to an increase in the analyte concentration in the vapor phase. Moreover, the heating time makes a greater contribution to the formation of the analytical signal than the temperature. The step of motion along the gradient was calculated and the experiments of steep ascent were carried out. Conclusion. According to the results of the steep ascent experiments, the optimal conditions for the gas extraction of formaldehyde in the form of a derivative were chosen.

scholarly journals Navigating the Quagmire: Comparison and Interpretation of COVID-19 Vaccine Phase 1/2 Clinical Trials

Vaccines ◽  
2020 ◽  
Vol 8 (4) ◽  
pp. 746
Author(s):  
Luca Tudor Giurgea ◽  
Matthew James Memoli
Keyword(s):  
Adverse Events ◽  
Protective Efficacy ◽  
Phase 1 ◽  
Phase 3 ◽  
Serious Adverse Events ◽  
Safety Studies ◽  
Antibody Titers ◽  
Public Health Strategies

Vaccines against Coronavirus Disease 2019 Originated-19) have been developed with unprecedented rapidity, many utilizing novel strategies. As of November 2020, a series of publications have outlined the results of phase 1/2 studies of nine different vaccines planned to move forward to phase 3 trials. The results are encouraging, demonstrating a paucity of severe or serious adverse events and robust induction of antibody titers. Determination of the vaccine candidates with the highest protective efficacy and best adverse event profiles will be essential in refining public health strategies. However, differences in study design and reporting of data make comparisons of existing phase 1/2 studies difficult. With respect to safety, studies have variable follow-up times and may use different definitions for adverse events. Immunogenicity outcomes are even more inconsistent, with variations in timepoints and critical differences in the types of antibodies studied as well as methodological differences in assays. Furthermore, the correlates of protection in COVID-19 are not known. Harmonization of phase 3 trial designs and use of objective and meaningful clinical outcomes will be crucial in streamlining future global responses to the pandemic.

scholarly journals Controlled Human Hookworm Infection: Accelerating Human Hookworm Vaccine Development

2018 ◽  
Vol 5 (5) ◽  
Author(s):  
David Diemert ◽  
Doreen Campbell ◽  
Jill Brelsford ◽  
Caitlyn Leasure ◽  
Guangzhao Li ◽  
...  
Keyword(s):  
Vaccine Development ◽  
Phase 1 ◽  
Gastrointestinal Symptoms ◽  
The United States ◽  
Good Manufacturing Practice ◽  
Application Site ◽  
Central Component ◽  
Hookworm Infection ◽  
Patent Infection

Abstract Background Controlled human hookworm infection (CHHI) is a central component of a proposed hookworm vaccination-challenge model (HVCM) to test the efficacy of candidate vaccines. Critical to CHHI is the manufacture of Necator americanus infective larvae (NaL3) according to current Good Manufacturing Practice (cGMP) and the determination of an inoculum of NaL3 that is safe and reliably induces patent infection. Methods cGMP-grade NaL3 were produced for a phase 1 trial in 20 healthy, hookworm-naïve adults in the United States, who received either 25 or 50 NaL3. Participants were monitored for 12–18 weeks postinfection for safety, tolerability, and patency of N. americanus infection. Results Both NaL3 doses were well tolerated. Early manifestations of infection included pruritus, pain, and papulovesicular rash at the application site. Gastrointestinal symptoms and eosinophilia appeared after week 4 postinfection. The 50 NaL3 inoculum induced patent N. americanus infection in 90% of this dose group. Conclusions The inoculum of 50 NaL3 was well tolerated and consistently induced patent N. americanus infection suitable for future HVCM trials. Clinical Trials Registration NCT01940757.

Sign in / Sign up

Export Citation Format

Share Document